Related references
Note: Only part of the references are listed.Romiplostim in patients undergoing hematopoietic stem cell transplantation: results of a phase 1/2 multicenter trial
Regis Peffault de latour et al.
BLOOD (2020)
Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation
Cai Yuan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide
Mitchell E. Horwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome
Yu Akahoshi et al.
HEMATOLOGICAL ONCOLOGY (2018)
European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute Leukemia Receiving Single Umbilical Cord Blood Transplantation
Xiaoyu Zhu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Recombinant Human Thrombopoietin Promotes Platelet Engraftment and Improves Prognosis of Patients with Myelodysplastic Syndromes and Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation
Hong Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy
Zhangyuan Kong et al.
BLOOD (2017)
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery
Rohtesh S. Mehta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies
Juliet N. Barker et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Characterization of thrombopoietin kinetics within 60 days after allogeneic hematopoietic stem cell transplantation and its correlation with megakaryocyte ploidy distribution
Haixia Fu et al.
CLINICAL TRANSPLANTATION (2016)
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia
Matthieu Mahevas et al.
BLOOD (2016)
Cord-Blood Transplantation in Patients with Minimal Residual Disease
Filippo Milano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Platelet Transfusion: A Clinical Practice Guideline From the AABB
Richard M. Kaufman et al.
ANNALS OF INTERNAL MEDICINE (2015)
Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation
Shernan G. Holtan et al.
BLOOD (2015)
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP
Hai Zhou et al.
BLOOD (2015)
Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial
Ting-ting Han et al.
ANNALS OF HEMATOLOGY (2015)
The new thrombopoietic agenda: Impact on leukemias and MDS
James B. Bussel
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2014)
Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy
Mary Eapen et al.
BLOOD (2014)
Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia
Satoshi Nishikawa et al.
BLOOD (2014)
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Philippe Armand et al.
BLOOD (2014)
Umbilical cord blood transplantation: the first 25 years and beyond
Karen K. Ballen et al.
BLOOD (2013)
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients
Jorge Labrador et al.
HAEMATOLOGICA (2013)
The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO
Fu-Sheng Chou et al.
BLOOD (2012)
Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling
John Anto Pulikkan et al.
BLOOD (2012)
Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation
Michael Roth et al.
BLOOD (2012)
Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture
Marcos de Lima et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prolonged Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation and Its Association with a Reduction in Ploidy and an Immaturation of Megakaryocytes
Xiaohui Zhang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions
Hongtao Liu et al.
BLOOD (2011)
Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes
Zhi-Jian Liu et al.
BLOOD (2011)
Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival
P. Ramirez et al.
BONE MARROW TRANSPLANTATION (2011)
Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on megakaryopoiesis of patients with lower risk myelodysplastic syndrome
Irene Mavroudi et al.
LEUKEMIA RESEARCH (2011)
Thrombopoietin-Receptor Agonists for Primary Immune Thrombocytopenia
Paul Imbach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A prototype nonpeptidyl, hydrazone class, thrombopoietin receptor agonist, SB-559457, is toxic to primary human myeloid leukemia cells
Anna Kalota et al.
BLOOD (2010)
Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies
Juliet N. Barker et al.
BLOOD (2010)
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
James B. Bussel et al.
BLOOD (2009)
Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome
Britta Will et al.
BLOOD (2009)
Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Celso A. Rodrigues et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia:: a phase I/II study
Francesco Frassoni et al.
LANCET ONCOLOGY (2008)
Umbilical cord blood produces small megakaryocytes after transplantation
Mark Ignatz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover
R. Yamazaki et al.
BONE MARROW TRANSPLANTATION (2006)
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia
MJ Laughlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia
V Rocha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood
LF Schipper et al.
EXPERIMENTAL HEMATOLOGY (2003)
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
JE Wagner et al.
BLOOD (2002)
Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor
RL Basser et al.
BLOOD (2002)
Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release
G Mattia et al.
BLOOD (2002)
Thrombocytopenia caused by the development of antibodies to thrombopoietin
JZ Li et al.
BLOOD (2001)
Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin-induced differentiation
R Bornstein et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Effect of thrombopoietin on proliferation of blasts from patients with myelodysplastic syndromes
SS Luo et al.
STEM CELLS (2000)
Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant
S Kanamaru et al.
STEM CELLS (2000)
Share Paper
